Study of 9MW2821 for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called 9MW2821, alone or with other treatments, for people with advanced solid tumors. It aims to see if the drug can shrink or slow the growth of cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a type of solid tumor cancer that has come back or spread to other parts of the body.
- You are able to do your daily activities with little or no help (ECOG score 0 or 1).
- You have not had chemotherapy or radiation in the last 3 weeks.
- You have not had another cancer in the last 3 years (except certain skin cancers).
- You agree to use effective birth control during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called 7MW4911 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective, and may be an option if you have a tumor that expresses a certain protein (CDH17).
This Phase 1 study tests 9MW2821 in people with advanced solid cancers that have grown despite earlier treatment. It aims to find the safest dose and learn how the drug works, and it may be an option if you can provide tumor tissue and meet key health criteria.
This trial tests a new drug combination for women with advanced gynecologic tumors that have not responded to standard treatments. Participants receive 9MW2821 along with other anti-cancer drugs to see if the combination is safe and effective.
This trial tests a new drug, 9MW2821 (sometimes with a PD-1 inhibitor), for people with advanced triple-negative breast cancer. It may be an option if you've already tried standard treatments or haven't started any yet.
This study tests a combination of two experimental cancer-fighting drugs (CVL006 and 9MW2821) in patients with advanced solid tumors, particularly head and neck cancer. The goal is to see if this combination can slow tumor growth and improve outcomes in patients whose cancers have not responded to standard treatments.
This trial tests a new drug called XNW29016 for people with advanced cancer that has stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.